Temaz vs. Lorazepam: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Temaz and Lorazepam. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 287,771 people who take Temaz and Lorazepam, and is updated regularly.
What is Temaz?
Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,293 Temaz users. Check the latest studies of Temaz.
What is Lorazepam?
Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.
287,771 people who take Temaz and Lorazepam are studied.

Drugs being compared in this study:
- Lorazepam (lorazepam)
- Temaz (temazepam)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Temaz:
- not at all: 3.9 %
- somewhat: 27.1 %
- moderate: 34.7 %
- high: 23.68 %
- very high: 10.62 %
Lorazepam:
- not at all: 2.43 %
- somewhat: 21.41 %
- moderate: 34.83 %
- high: 29.5 %
- very high: 11.83 %
Want to compare Temaz with Lorazepam?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Temaz:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lorazepam:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on temazepam and lorazepam (the active ingredients of Temaz and Lorazepam, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Oxycodone vs. Fentanyl Citrate, side effect and effectiveness comparison - 15 seconds ago
- Letrozole and Atrial Fibrillation/Flutter for Women aged 50-59 - 15 seconds ago
- Letrozole and Atrial Flutter for Women aged 50-59 - 16 seconds ago
- Letrozole and Atrial Fibrillation for Women aged 50-59 - 16 seconds ago
- Letrozole and Auricular Fibrillation for Women aged 50-59 - 16 seconds ago
- Letrozole and A-Fib for Women aged 50-59 - 17 seconds ago
- Letrozole and Heart Fibrillation for Women aged 50-59 - 17 seconds ago
- Diclofenac Sodium and Multiple Sclerosis Relapse for Women aged 40-49 - 18 seconds ago
- Atorvastatin Calcium and Acute Coronary Syndrome for Men aged 50-59 - 19 seconds ago
- Azacitidine and General Physical Health Deterioration for Men aged 50-59 - 19 seconds ago